微生物来源的免疫抑制剂国内外生产研发状况及市场分析

如今器官移植已经成为现代医学治疗的重要手段之一,但是移植产生的排斥反应给患者的治疗带来了极大的风险。免疫抑制剂的使用有效地抑制了这种危险,并提高了器官移植的成功率。其中,微生物产生的免疫抑制剂占据了绝大部分市场份额。另外,随着生物技术的不断应用,微生物来源的免疫抑制剂新品种的不断涌现给进行器官移植的患者带来了福音。本文分析了该类免疫抑制剂的国内外生产状况、研发进展及市场信息,以期为相关企业制定营销战略决策起导向作用。

Abroad and home production situations,R&D progress and market analysis of immunosuppressive agents from microorganisms

Currently organ transplantation has been applied as one of the important means of medical treatment,but allograft rejection has brought great risk to patients.The use of immunosuppressive agents has restrained the danger and increased the success rate of organ transplantation.Among these agents,the immunosuppressive agents from microorganisms had made up an absolute share in the market.In addition,with the continuous application of biotechnology,the introductions of new products had brought good news to pat...